Black Mountain, North Carolina, April 30, 2018 (Newswire) – ALP Life Sciences, Inc. today announced its new and improved ALP High 3 Omega 3 fish oil supplement in triglyceride form. The new formulation of ALP High 3 contains over 1600 mg of EPA and DHA in a daily serving of...
ALP News
Stay Up To Date With The Latest From ALP Life Sciences
ALP Life Sciences Announces ALP High 3
ALP High 3 the New Omega 3 Fish Oil Formulated for Maximum Absorption and Bioavailability ALP Life Sciences, LLC today announced that its ALP High 3 Omega 3 fish oil supplement in triglyceride form, with 1200 mg of EPA and DHA in a daily serving of two soft gels, is...
ALP Life Sciences, LLC Announces Nanoveson(TM) Patent Filing on Proposed Therapy for Non-Alcoholic Fatty Liver Disease (NAFLD) and Comorbid Disease
ALP Life Sciences, LLC (Company) today announced the Nanoveson(TM) patent has been filed. After completing initial research, the Company is pursuing clinical trials and FDA regulatory approval of Nanoveson(TM) as a prescription drug treatment for non-alcoholic fatty liver disease (NAFLD). Over 60 million adult Americans suffer from NAFLD and these...
60 Softgels
only
$34.95FREE S+H
SAVE UP TO 20% OFF
WHEN YOU BUY MULTIPLE
More than 1400mg of ultra-pure EPA/DHA
Fastest growing product in more than 50 pharmacies
